ArticleHealth services research and managerial epidemiology
Review of Diagnosis-Related Group-Based Financing of Hospital Care.
Article in Health services research and managerial epidemiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
62 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- The economic impact of anastomotic leakage after colorectal surgery: a systematic review.Techniques in coloproctology · 2024Pooled it
- A Systematic Review and Multilevel Regression Analysis Reveals the Comorbidity Prevalence in Cancer.Cancer research · 2023Pooled it
- Comparing financing models for supplementary healthcare in appendectomy: activity-based costing (fee-for-service) vs. diagnosis related group remuneration (bundled payment) - a systematic review and meta-analysis.Acta cirurgica brasileira · 2023Pooled it
- Pediatric Neurosurgery Procedural Coding: Current Lay of the Land.Neurosurgery practice · 2026Article
- Analyzing hospital behavior across different payment mechanism as a response to financial incentives - a scoping review.BMC health services research · 2026Article
- Payment mechanism and medical quality: new evidence from China healthcare reform.BMC health services research · 2026Article
- From Paper to Platform: Updating the Dutch Costing Manual and Launching a Web Application.PharmacoEconomics · 2026Article
- A data and knowledge cross-level fusion-driven learning framework for detecting missing diagnosis.NPJ digital medicine · 2026Article
- Trust by design: the effects of personal interest vs. social responsibility frame on policy acceptance and patient trust in China's DRG reform.BMC health services research · 2026Article
- Behavioral responses of healthcare providers to prospective payment systems: a systematic review using the WHO framework (2000-2024).Health economics review · 2026Review
- Cost Disparities Between Hospital Expenditures and Reimbursement Schemes in Indonesia: A Study on Chemotherapy for Breast Cancer.Asian Pacific journal of cancer prevention : APJCP · 2026Article
- Do non-local hospitalized patients cost more? A comparative study based on the implementation of the DRG payment.Frontiers in public health · 2026Article
- Article
- Improved management of hospital-acquired infections with DRG-based payment system: an interrupted time‑series analysis.BMC health services research · 2025Article
- Assessing healthcare payment reforms' effects on economic inequities and catastrophic expenditures among cancer patients in ethnic minority regions of China.BMC medicine · 2025Article
- Article
- Enlightening Nursing Care: A Protocol for a Multicenter Observational Study Measuring Nursing Work in Hospital Settings.Healthcare (Basel, Switzerland) · 2025Article
- Cost shifting or cost cutting by hospitals as a response to reimbursement reform? The case of diagnosis-related groups (DRG) scheme in China.Frontiers in public health · 2025Article
- Impacts of DRG point-based payment system on healthcare resource utilization and provider behavior: a pilot quasi-experimental study in China.Frontiers in public health · 2025Article
- Deep learning for cardiovascular management: optimizing pathways and cost control under diagnosis-related group models.Frontiers in artificial intelligence · 2025Review
2 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since the 1990s, diagnosis-related group (DRG)-based payment systems were gradually introduced in many countries. The main design characteristics of a DRG-based payment system are an exhaustive patient case classification system (ie, the system of diagnosis-related groupings) and the payment formula, which is based on the base rate multiplied by a relative cost weight specific for each DRG. Cases within the same DRG code group are expected to undergo similar clinical evolution. Consecutively, they should incur the costs of diagnostics and treatment within a predefined scale. Such predictability was proven in a number of cost-of-illness studies conducted on major prosperity diseases alongside clinical trials on efficiency. This was the case with risky pregnancies, chronic obstructive pulmonary disease, diabetes, depression, alcohol addiction, hepatitis, and cancer. This article presents experience of introduced DRG-based payments in countries of western and eastern Europe, Scandinavia, United States, Canada, and Australia. This article presents the results of few selected reviews and systematic reviews of the following evidence: published reports on health system reforms by World Health Organization, World Bank, Organization for Economic Co-operation and Development, Canadian Institute for Health Information, Canadian Health Services Research Foundation, and Centre for Health Economics University of York. Diverse payment systems have different strengths and weaknesses in relation to the various objectives. The advantages of the DRG payment system are reflected in the increased efficiency and transparency and reduced average length of stay. The disadvantage of DRG is creating financial incentives toward earlier hospital discharges. Occasionally, such polices are not in full accordance with the clinical benefit priorities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.